Publication:
Stenotrophomonas maltophilia infections: Clinical characteristics and factors associated with mortality of hospitalized patients

dc.contributor.authorWorachart Insuwannoen_US
dc.contributor.authorPattarachai Kiratisinen_US
dc.contributor.authorAnupop Jitmuangen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-08-25T11:14:05Z
dc.date.available2020-08-25T11:14:05Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020 Insuwanno et al. Purpose: To study the clinical characteristics and factors associated with mortality of patients who had Stenotrophomonas maltophilia infections. Patients and Methods: We conducted a retrospective study to determine the clinical characteristics and factors associated with mortality for S. maltophilia infections among hospitalized adult patients at Siriraj Hospital. The clinical and microbiological data were collected from medical records December 2013–December 2016. Results: Of 1221 subjects whose clinical samples grew S. maltophilia, 213 were randomly selected for chart review. One hundred patients with a true infection were analyzed. Their median age was 66 years; 47 were males; 46 were critically ill with a median APACHE II score of 18 (2–32); and 91 received antibiotic treatment, mainly with carbapenems (56%), before being diagnosed with a S. maltophilia infection. Pulmonary (53%) and bloodstream infections (25%) were the most common infections. The median length of hospitalization was 19 days before infection onset. The in-hospital mortality rate was 54%. The following factors were associated with mortality: a pre-existing respiratory infection (OR 6.28, 1.33–-29.78; p.021); critical illness (OR 3.33, 1.45–7.62; p.005); multi-organ dysfunction (OR 2.44, 1.05–5.70; p.039); being on mechanical ventilation (OR 4.44, 1.90–10.39; p.001); concurrent immunosuppressive therapy (OR 2.67, 1.10–6.47; p.029); intravascular (OR 4.43, 1.79–10.92; p.001) and urinary catheterization (OR 4.83, 1.87–12.47; p.001); and serum albumin <3 g/dL (OR 4.13, 1.05–16.33; p.043). A multivariate analysis identified two independent factors associated with mortality: being on mechanical ventilation (OR 4.43, 1.86–10.59; p 0.001) and receiving concurrent immunosuppressive therapy (OR 2.26, 1.04–6.82; p 0.042). Conclusion: S. maltophilia can cause nosocomial infections with high mortality, particularly in patients with a prolonged hospitalization. Concurrent immunosuppressive therapy and being on mechanical ventilation are the independent factors associated with a fatal outcome.en_US
dc.identifier.citationInfection and Drug Resistance. Vol.13, (2020), 1559-1566en_US
dc.identifier.doi10.2147/IDR.S253949en_US
dc.identifier.issn11786973en_US
dc.identifier.other2-s2.0-85086162131en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/58268
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086162131&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleStenotrophomonas maltophilia infections: Clinical characteristics and factors associated with mortality of hospitalized patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086162131&origin=inwarden_US

Files

Collections